Daniel Hernandez-Vaquero1,2, Jacobo Silva1,3, Alain Escalera1, Rubén Álvarez-Cabo1, Carlos Morales1, Rocío Díaz1,2, Pablo Avanzas2,4,5, Cesar Moris2,4,5, Isaac Pascual2,4,5. 1. Cardiac Surgery Department, Central University Hospital of Asturias, 33011 Oviedo, Spain. 2. Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain. 3. Department of Surgery, University of Oviedo, 33011 Oviedo, Spain. 4. Department of Cardiology, Central University Hospital of Asturias, 33011 Oviedo, Spain. 5. Department of Medicine, University of Oviedo, 33011 Oviedo, Spain.
Abstract
Introduction: The life expectancy of patients who undergo ascending aortic replacement is unknown. The life expectancy of a population depends on a collection of environmental and socio-economic factors of the territory where they reside. Our aim was to compare the life expectancy of patients undergoing surgery for ascending aortic aneurysm with that of the general population matching by age, sex, and territory. In addition, we aimed to know the late complications, causes of death and risk factors. Methods: All patients who underwent elective replacement of an ascending aortic aneurysm at our institution between 2000 and 2019 were included. The long-term survival of the sample was compared with that of the general population using data of the National Institute of Statistics. Results: For patients who survived the postoperative period, observed cumulative survival at three, five and eight years was 94.07% (95% CI 91.87%-95.70%), 89.96% (95% CI 86.92%-92.33%) and 82.72% (95% CI 77.68%-86.71%). Cumulative survival of the general population at three, five and eight years was 93.22%, 88.30%, and 80.27%. Cancer and cardiac failure were the main causes of death. Conclusions: Long-term survival of patients undergoing elective surgery for ascending aortic aneurysm who survive the postoperative period completely recover their life expectancy.
Introduction: The life expectancy of patients who undergo ascending aortic replacement is unknown. The life expectancy of a population depends on a collection of environmental and socio-economic factors of the territory where they reside. Our aim was to compare the life expectancy of patients undergoing surgery for ascending aortic aneurysm with that of the general population matching by age, sex, and territory. In addition, we aimed to know the late complications, causes of death and risk factors. Methods: All patients who underwent elective replacement of an ascending aortic aneurysm at our institution between 2000 and 2019 were included. The long-term survival of the sample was compared with that of the general population using data of the National Institute of Statistics. Results: For patients who survived the postoperative period, observed cumulative survival at three, five and eight years was 94.07% (95% CI 91.87%-95.70%), 89.96% (95% CI 86.92%-92.33%) and 82.72% (95% CI 77.68%-86.71%). Cumulative survival of the general population at three, five and eight years was 93.22%, 88.30%, and 80.27%. Cancer and cardiac failure were the main causes of death. Conclusions: Long-term survival of patients undergoing elective surgery for ascending aortic aneurysm who survive the postoperative period completely recover their life expectancy.
Entities:
Keywords:
ascending aortic aneurysm; ascending aortic replacement; life expectancy
Authors: Daniel P Zalewski; Karol P Ruszel; Andrzej Stępniewski; Dariusz Gałkowski; Jacek Bogucki; Łukasz Komsta; Przemysław Kołodziej; Paulina Chmiel; Tomasz Zubilewicz; Marcin Feldo; Janusz Kocki; Anna Bogucka-Kocka Journal: J Clin Med Date: 2020-06-24 Impact factor: 4.241
Authors: Isaac Pascual; Daniel Hernandez-Vaquero; Marcel Almendarez; Rebeca Lorca; Alain Escalera; Rocío Díaz; Alberto Alperi; Manuel Carnero; Jacobo Silva; Cesar Morís; Pablo Avanzas Journal: J Clin Med Date: 2020-04-19 Impact factor: 4.241
Authors: Katelyn Monaghan; Felix Orelaru; Aroma Naeem; Rana-Armaghan Ahmad; Xiaoting Wu; Karen M Kim; Shinichi Fukuhara; Himanshu J Patel; G Michael Deeb; Bo Yang Journal: Cardiol Cardiovasc Med Date: 2021-12-03